Related Experiment Video
Updated: Jun 21, 2026
11:51
Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
Statistical and trial design considerations in central nervous system prophylaxis studies.
Jennifer A Smith1, Michael Glantz
1Geron Corp, Menlo Park, CA 94025, USA. jsmith@geron.com
Seminars in Oncology
|August 8, 2009
Summary
Prophylactic therapy offers a potential strategy for cancer patients at high risk of central nervous system (CNS) metastases. This article examines the rationale, feasibility, and ethical considerations for CNS prophylaxis trials.
Area of Science:
- Oncology
- Clinical Trials
- Neuro-oncology
Background:
- Central nervous system (CNS) involvement in cancer patients carries a very poor prognosis.
- Prophylactic therapy is a potential strategy for high-risk patients to prevent CNS metastases.
Purpose of the Study:
- To explore the rationale, feasibility, and ethics of prophylactic therapy for CNS metastases.
- To discuss study design considerations for CNS prophylaxis trials, including statistical issues.
Main Methods:
- Review of existing literature and clinical trial design principles.
- Discussion of innovative trial designs and operational strategies for limited patient pools.
- Presentation of proposed trial designs for glioblastoma multiforme and non-Hodgkin lymphoma.
Main Results:
- Limited patient pools necessitate innovative clinical trial designs.
- Strategies like risk factor enrichment and flexible accrual are crucial.
- Early termination techniques are important for poor initial outcomes.
Conclusions:
- Prophylactic therapy warrants further investigation for CNS metastases prevention.
- Careful consideration of study design, statistical issues, and operational strategies is essential for CNS prophylaxis trials.
- Innovative approaches are needed to address clinical questions in this patient population.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...